Polymyalgia rheumatica: A possible cause of pericardial effusion
Suspect polymyalgia in patients who continue to decline after treatment for pericardial effusion.
Musculoskeletal/Orthopedics
FDA announces recall of Stryker cutting guide for TKA
On April 19, the U.S. Food and Drug Administration (FDA) announced that Stryker Orthopaedics has recalled ShapeMatch Cutting Guides, used in total knee arthroplasty…
Study: Even minor increases in physical activity benefits bone health in premenopausal women
A study to be published in the Journal of Clinical Endocrinology and Metabolism found that physical activity, even minor increases, in premenopausal women is…
FDA seeks advice on metal-on-metal hip replacements
On March 29, the U.S. Food and Drug Administration (FDA) announced that a two-day expert advisory panel meeting on metal-on-metal hip replacement systems will…
FDA approves first generic versions of Boniva
On March 19, the U.S. Food and Drug Administration (FDA) approved the first generic versions of Boniva (ibandronate) tablets, used to treat osteoporosis. Read…
Use of bone morhphogenetic proteins not associated less reoperation for lumbar stenosis
A study in February’s Spine reports that use of bone morhphogenetic proteins (BMP) in spinal fusion surgery for older adults with lumbar stenosis reports…
Are you ready to care for patients in clinical trials?
Part 1 of a four-part series on clinical trials
NEJM study assess BMD retesting
A study in the Jan. 19 issue of The New England Journal of Medicine (NEJM) found that in older, postmenopausal women with normal bone…
FDA approves first drug for myelofibrosis
The U.S. Food and Drug Administration has approved Jakafi (ruxolitinb), the first drug approved to treat patients with the bone marrow disease myelofibrosis. Read…
Understanding pain in patients with intellectual disabilities
Learn how to detect and manage pain in patients who may not respond to pain in expected ways.
Polymyalgia rheumatica: A possible cause of pericardial effusion
Suspect polymyalgia in patients who continue to decline after treatment for pericardial effusion.
FDA announces recall of Stryker cutting guide for TKA
On April 19, the U.S. Food and Drug Administration (FDA) announced that Stryker Orthopaedics has recalled ShapeMatch Cutting Guides, used in total…
Study: Even minor increases in physical activity benefits bone health in premenopausal women
A study to be published in the Journal of Clinical Endocrinology and Metabolism found that physical activity, even minor increases, in premenopausal…
FDA seeks advice on metal-on-metal hip replacements
On March 29, the U.S. Food and Drug Administration (FDA) announced that a two-day expert advisory panel meeting on metal-on-metal hip replacement…
FDA approves first generic versions of Boniva
On March 19, the U.S. Food and Drug Administration (FDA) approved the first generic versions of Boniva (ibandronate) tablets, used to treat…
Use of bone morhphogenetic proteins not associated less reoperation for lumbar stenosis
A study in February’s Spine reports that use of bone morhphogenetic proteins (BMP) in spinal fusion surgery for older adults with lumbar…
Are you ready to care for patients in clinical trials?
Part 1 of a four-part series on clinical trials
NEJM study assess BMD retesting
A study in the Jan. 19 issue of The New England Journal of Medicine (NEJM) found that in older, postmenopausal women with…
FDA approves first drug for myelofibrosis
The U.S. Food and Drug Administration has approved Jakafi (ruxolitinb), the first drug approved to treat patients with the bone marrow disease…
Understanding pain in patients with intellectual disabilities
Learn how to detect and manage pain in patients who may not respond to pain in expected ways.
Poll
Preferred way to get content
Get your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.
NurseLine Newsletter
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.